Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brendan Lichtenthal

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Expert Opinion on Therapeutic Patents|December 15, 2015
Taxane anticancer agents: a patent perspectiveIwao Ojima, Brendan Lichtenthal, Siyeon Lee, et al.
Journal of Fluorine Chemistry|February 28, 2015
Design, Synthesis and Application of Fluorine-Labeled Taxoids as <sup>19</sup>F NMR Probes for the Metabolic Stability Assessment of Tumor-Targeted Drug Delivery SystemsJoshua D Seitz, Jacob G Vineberg, Longfei Wei, et al.
Analytical Chemistry|January 5, 2026
Multiplatform Benchtop NMR Interlaboratory Study of Model Liquid Dosage Forms of Pharmaceutical ProductsKatharine T Briggs, Frank Delaglio, Marc B Taraban, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Expert Opinion on Therapeutic Patents|December 15, 2015
Taxane anticancer agents: a patent perspectiveIwao Ojima, Brendan Lichtenthal, Siyeon Lee, et al.
Journal of Fluorine Chemistry|February 28, 2015
Design, Synthesis and Application of Fluorine-Labeled Taxoids as <sup>19</sup>F NMR Probes for the Metabolic Stability Assessment of Tumor-Targeted Drug Delivery SystemsJoshua D Seitz, Jacob G Vineberg, Longfei Wei, et al.
Analytical Chemistry|January 5, 2026
Multiplatform Benchtop NMR Interlaboratory Study of Model Liquid Dosage Forms of Pharmaceutical ProductsKatharine T Briggs, Frank Delaglio, Marc B Taraban, et al.
Pageof 1